Kanabo Group (LON:KNB) Sets New 12-Month Low – What’s Next?

Kanabo Group Plc (LON:KNB) shares hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as GBX 0.92 ($0.01) and last traded at GBX 0.92 ($0.01), with a volume of 1250580 shares changing hands. The stock had previously closed at GBX 1.06 ($0.01).

Kanabo Group Stock Down 11.3 %

The company has a debt-to-equity ratio of 3.49, a current ratio of 2.78 and a quick ratio of 24.36. The stock has a market capitalization of £5.94 million, a P/E ratio of -120.00 and a beta of 3.04. The firm has a 50 day moving average of GBX 1.16 and a 200-day moving average of GBX 1.38.

Insider Activity at Kanabo Group

In other news, insider Ian Mattioli purchased 150,000 shares of the stock in a transaction that occurred on Tuesday, August 27th. The shares were purchased at an average cost of GBX 1 ($0.01) per share, for a total transaction of £1,500 ($1,945.27). Corporate insiders own 37.01% of the company’s stock.

Kanabo Group Company Profile

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain.